Skip to main content
. 2011 Jun 28;2011:727634. doi: 10.4061/2011/727634

Figure 2.

Figure 2

6-month medical treatment costs for patients in remission (a), low disease activity state (b), and moderate to high disease activity (c), excluding biological drug costs (in Euros).